Valuation Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 09:06:14 08/09/2026 pm IST			5-day change	1st Jan Change
244.90 ^EUR	-1.01%		-2.24%	+42.51%

08/09	Charles River Laboratories International Implements Endosafe Cartridge Technology Automated Manufacturing Suite	CI
21/08	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	13,403	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	33.72%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	15,515	15,034	14,640
Change	-	-36.28%	7.39%	-20.91%	3.29%	29.88%	-3.1%	-2.62%
P/E	49.4x	23.1x	25.9x	931x	-70x	75.1x	32.2x	26.9x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.45x	3.78x	3.36x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	1.4x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.43x	3.35x	3.19x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	3.97x	3.76x	3.48x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.4x	13.8x	12.5x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	18.9x	16.5x	14.6x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	49.2x	24.7x	30.7x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2.03%	4.05%	3.26%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.738	8.718	10.43
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,911	4,001	4,208
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,008	1,093	1,174
EBIT ¹	742.1	834	838.8	805.9	793.9	821	912.3	1,001
Net income ¹	391	486.2	474.6	10.3	-144.3	162.4	427.7	471.2
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,631	1,237
Reference price ²	375.34	218.92	238.84	186.16	203.66	280.76	280.76	280.76
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
LONZA GROUP AG	32.76x	5.88x	17.63x	0.99%	4.84TCr
REVOLUTION MEDICINES, INC.	-21.5x	245.64x	-23.19x	-.--%	4.5TCr
IQVIA HOLDINGS INC.	34.48x	3.33x	14.35x	-.--%	4.41TCr
BEONE MEDICINES AG	46.93x	5.43x	29.72x	-.--%	4.07TCr
CELLTRION, INC.	28.26x	8.5x	21.55x	0.4%	3.32TCr
MEDPACE HOLDINGS, INC.	33.62x	5.51x	25.02x	-.--%	1.65TCr
EUROFINS SCIENTIFIC SE	23.87x	2.08x	9x	1.13%	1.45TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.18x	4.06x	15.75x	-.--%	1.38TCr
Average	31.95x	35.05x	13.73x	0.32%	3.2TCr
Weighted average by Cap.	27.13x	47.50x	12.21x	0.3%